The global spatial genomics and transcriptomics market size was estimated to be USD 0.28976 billion in 2023 and is expected to reach at USD 1.0627 billion by 2033 with a CAGR of 12.54% during the forecast period 2023-2033. Rising demand of spatial genomics & transcriptomics in drug discovery and development, growing demand for personalized medicine, surge in identification of novel biomarkers for diagnosis, increasing demand for cancer detection tool, rising in investments in research & development activities, growing prevalence of chronic diseases such as cancer, increasing need of advanced diagnostics, and surge in introduction of advanced technologies are some of the key factors propelling the market growth.
Surge in introduction of advanced technologies is predicted to boost the market growth during the forecast period. For instance, in May 2022, NanoString has introduced a streamlined, web-based process that enhances the analysis of spatial data for customers utilizing Illumina's NextSeq 1000 and NextSeq 2000 sequencing systems and the GeoMx Digital Spatial Profiler. This advancement aims to simplify spatial biology research by integrating next-generation sequencing technology.
By Products, Consumables was the highest revenue-grossing segment in the global spatial genomics and transcriptomics market in 2022 owing to the surge in use of consumables for spatial genomics & transcriptomics applications, increasing new product launches, surge in partnerships and collaborations within market players. For instance, in October 2022, Oxford Nanopore Technologies and 10x Genomics have formed a collaboration to manufacture consumables that support single-cell and spatial transcript sequencing, with a particular emphasis on capturing complete-length isoforms. Additionally, Instruments is predicted to grow at fastest CAGR during the forecast period owing to the rising development of new instruments, increasing research & development activities.
By Technology, Spatial Transcriptomics was the highest revenue-grossing segment in the global spatial genomics and transcriptomics market in 2022 owing to the rising adoption of in situ sequencing methods, increasing demand for nucleic acid sequencing of biological samples or single cells, enhanced knowledge of tissue heterogeneity, surge in launch of number of innovative sequencing techniques. For instance, in February 2023, Curio Bioscience has introduced Curio Seeker, a comprehensive spatial mapping kit that enables high-resolution imaging and analysis of the entire transcriptome. Additionally, Spatial genomics is predicted to grow at fastest CAGR during the forecast period owing to the rising improvements in genome modification technologies like the CRISPR/Cas9 system and increasing adoption of in situ sequencing techniques.
By End-user, Translational research was the highest revenue-grossing segment in the global spatial genomics and transcriptomics market in 2022 owing to the rising usage of spatial omics technologies in translational research, increasing introduction of new diagnostic tools and therapeutics, and growing research and development activities. For instance, in April 2023, Bio-Techne and Lunaphore have joined forces to create the world's inaugural automated spatial omics multiworkflow. This collaborative effort aims to design and develop a system that offers unparalleled flexibility in panel design, enabling comprehensive spatial analysis in the field of omics research. Additionally, Academic Customers is predicted to grow at fastest CAGR during the forecast period owing to the increasing usage of spatial genomic analyses in academic research institutions and rising research & development activities.
North America region is anticipated for the highest revenue share during the forecast period owing to the growing prevalence of cancer cases, rising demand for advanced diagnostics such as spatial genomics and transcriptomics, increasing investments in research & development activities, growing focus on transcriptomics R&D, rising novel product launches, and surge in collaborations & partnerships within market players. For instance, in October 2022, Illumina and AstraZeneca have entered into a strategic research partnership with the objective of expediting the discovery of drug targets. By leveraging their respective competencies in AI-driven genome interpretation, genomic analysis methods, and industry knowledge, the collaboration aims to enhance the process of identifying potential targets for drug development. Additionally, Asia Pacific region is predicted to grow at a fastest CAGR during the forecast period owing to the rising research & development activities, growing healthcare expenditures, and increasing collaborations between major market players & regional research institutes. For instance, in June 2022, MiRXES, a biotechnology company based in Singapore, has revealed a strategic alliance with BGI-Research and MGI. The objective of this partnership is to enhance and expedite research in the areas of spatio-temporal transcriptomics and multi-omics, specifically focusing on human development and diseases.
Surge in introduction of advanced technologies is predicted to boost the market growth during the forecast period. For instance, in May 2022, NanoString has introduced a streamlined, web-based process that enhances the analysis of spatial data for customers utilizing Illumina's NextSeq 1000 and NextSeq 2000 sequencing systems and the GeoMx Digital Spatial Profiler. This advancement aims to simplify spatial biology research by integrating next-generation sequencing technology.
By Products, Consumables was the highest revenue-grossing segment in the global spatial genomics and transcriptomics market in 2022 owing to the surge in use of consumables for spatial genomics & transcriptomics applications, increasing new product launches, surge in partnerships and collaborations within market players. For instance, in October 2022, Oxford Nanopore Technologies and 10x Genomics have formed a collaboration to manufacture consumables that support single-cell and spatial transcript sequencing, with a particular emphasis on capturing complete-length isoforms. Additionally, Instruments is predicted to grow at fastest CAGR during the forecast period owing to the rising development of new instruments, increasing research & development activities.
By Technology, Spatial Transcriptomics was the highest revenue-grossing segment in the global spatial genomics and transcriptomics market in 2022 owing to the rising adoption of in situ sequencing methods, increasing demand for nucleic acid sequencing of biological samples or single cells, enhanced knowledge of tissue heterogeneity, surge in launch of number of innovative sequencing techniques. For instance, in February 2023, Curio Bioscience has introduced Curio Seeker, a comprehensive spatial mapping kit that enables high-resolution imaging and analysis of the entire transcriptome. Additionally, Spatial genomics is predicted to grow at fastest CAGR during the forecast period owing to the rising improvements in genome modification technologies like the CRISPR/Cas9 system and increasing adoption of in situ sequencing techniques.
By End-user, Translational research was the highest revenue-grossing segment in the global spatial genomics and transcriptomics market in 2022 owing to the rising usage of spatial omics technologies in translational research, increasing introduction of new diagnostic tools and therapeutics, and growing research and development activities. For instance, in April 2023, Bio-Techne and Lunaphore have joined forces to create the world's inaugural automated spatial omics multiworkflow. This collaborative effort aims to design and develop a system that offers unparalleled flexibility in panel design, enabling comprehensive spatial analysis in the field of omics research. Additionally, Academic Customers is predicted to grow at fastest CAGR during the forecast period owing to the increasing usage of spatial genomic analyses in academic research institutions and rising research & development activities.
North America region is anticipated for the highest revenue share during the forecast period owing to the growing prevalence of cancer cases, rising demand for advanced diagnostics such as spatial genomics and transcriptomics, increasing investments in research & development activities, growing focus on transcriptomics R&D, rising novel product launches, and surge in collaborations & partnerships within market players. For instance, in October 2022, Illumina and AstraZeneca have entered into a strategic research partnership with the objective of expediting the discovery of drug targets. By leveraging their respective competencies in AI-driven genome interpretation, genomic analysis methods, and industry knowledge, the collaboration aims to enhance the process of identifying potential targets for drug development. Additionally, Asia Pacific region is predicted to grow at a fastest CAGR during the forecast period owing to the rising research & development activities, growing healthcare expenditures, and increasing collaborations between major market players & regional research institutes. For instance, in June 2022, MiRXES, a biotechnology company based in Singapore, has revealed a strategic alliance with BGI-Research and MGI. The objective of this partnership is to enhance and expedite research in the areas of spatio-temporal transcriptomics and multi-omics, specifically focusing on human development and diseases.
Segmentation: Spatial Genomics And Transcriptomics Market Report 2022 - 2033
Spatial Genomics And Transcriptomics Market Analysis & Forecast by Product 2022 - 2033 (Revenue USD Mn)
- Consumables
Software
- Imaging Tools
- Bioinformatics Tools
- Storage and Management Databases
Instruments
- By Mode
- Manual
- Automated
Semi-automated
- By Type
- IHC
- Flow Cytometry
- Microscopy
- Mass Spectrometry
- Sequencing Platforms
- Others
Spatial Genomics And Transcriptomics Market Analysis & Forecast by Technology 2022 - 2033 (Revenue USD Mn)
Spatial Genomics
- FISH
- Biochemical Techniques
- Genome Perturbation Tools
- Massively-Parallel Sequencing
- Microscopy-based Live DNA Imaging
- Others
Spatial Transcriptomics
- IHC
- Microscopy-based RNA Imaging Techniques
- Branched DNA Probes
- Padlock Probes/ Rolling Circle Amplification
Single Molecule RNA Fluorescence In-Situ Hybridization (smFISH)
- Sequencing-Based Methods
- Microtomy Sequencing
- In Situ Sequencing
- Transcriptome In-Vivo Analysis (TIVA)
- Laser Capture Microdissection (LCM)
- FFPE Tissue Samples
- Others
Spatial Genomics And Transcriptomics Market Analysis & Forecast by End-user 2022 - 2033 (Revenue USD Mn)
- Academic Customers
- Translational Research
- Pharmaceutical Manufacturer
- Diagnostic Customers
Spatial Genomics And Transcriptomics Market Analysis & Forecast by Region 2022 - 2033 (Revenue USD Mn)
North America
- U.S.
- Canada
Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Spatial Genomics And Transcriptomics Market: Product Estimates & Trend Analysis
8. Spatial Genomics And Transcriptomics Market: Technology Estimates & Trend Analysis
9. Spatial Genomics And Transcriptomics Market: End-user Estimates & Trend Analysis
10. Regional Market Analysis
11. North America Spatial Genomics And Transcriptomics Market
12. Europe Global Spatial Genomics And Transcriptomics Market
13. Asia Pacific Global Spatial Genomics And Transcriptomics Market
14. Latin America Global Spatial Genomics And Transcriptomics Market
15. MEA Global Spatial Genomics And Transcriptomics Market
16. Competitor Analysis
17. Company Profiles
Companies Mentioned
- Natera Inc.
- 10x Genomics
- Dovetail Genomics
- Illumina Inc.
- S2 Genomics Inc.
- NanoString Technologies Inc.
- Seven Bridges Genomics
- Horizon Discovery Group plc
- Bio-Techne
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 145 |
| Published | August 2023 |
| Forecast Period | 2022 - 2033 |
| Estimated Market Value ( USD | $ 0.29 Billion |
| Forecasted Market Value ( USD | $ 1.06 Billion |
| Compound Annual Growth Rate | 12.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 9 |
